Lotus Eye Hospital And Institute (NSE: LOTUSEYE, BSE: 532998) is a Coimbatore, Tamil Nadu-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹238 Cr, it ranks #2,515 by market cap among the 6,137 Indian listed companies on FinBizNet, and #24 of 42 in Hospitals and Healthcare Centers. At ₹112.40 (as of 25 Oct 2026), the share price is 23.5% below its 52-week high of ₹147.00 and 15.2% above its 52-week low of ₹97.59. The share price is down 8.2% over one year and down 5.6% over three months.
| Current Price | ₹112.40 |
|---|---|
| Market Cap | ₹238 Cr |
| NSE Symbol | LOTUSEYE |
| BSE Code | 532998 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 2,750 |
| Return on Equity | 0.13% |
| Return on Assets | 0.07% |
| 52-Week Range | ₹97.59 – ₹147.00 |
| 1-Year Price Change | -8.2% |
| 3-Month Price Change | -5.6% |
| Beta (1Y) | 0.1 |
| Dividend Yield | 0.00% |
| Headquarters | Coimbatore, Tamil Nadu |
| Website | www.lotuseye.org |
| Revenue | ₹17 Cr |
|---|---|
| Net Profit | ₹1 Cr |
| Net Margin | 3.6% |
| EPS (Basic) | ₹0.30 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 198
1. Providing Health Care (Eye Care) Services-This segment engages in the provision of healthcare services in India. It provides services in the areas of cataract, retina, glaucoma, refractive surgery, cornea, orbit and oculoplasty, squint, uvea, neuro and paediatric ophthalmology, headache, and low vision aid.
1. Eye Care Related Sales and Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Lotus Eye Hospital And Institute | ₹238 Cr | 2,750 | 0.13% | ₹17 Cr | -8.2% |
Listed by market capitalisation. Ratios are shown for context only.
Lotus Eye Hospital And Institute is trading at ₹112.40, with a market capitalisation of ₹238 Cr.
Lotus Eye Hospital And Institute operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Lotus Eye Hospital And Institute has a P/E of 2,750 and a return on equity of 0.13%.
Lotus Eye Hospital And Institute is listed on the NSE under the symbol LOTUSEYE and on the BSE under the scrip code 532998.
Lotus Eye Hospital And Institute's share price is down 8.2% over one year and down 5.6% over three months. Its 52-week range is ₹97.59 to ₹147.00.
In Q1 FY27, Lotus Eye Hospital And Institute reported revenue of ₹17 Cr and net profit of ₹1 Cr, with basic EPS of ₹0.3 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.